U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H35NO
Molecular Weight 281.4766
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ELAIDAMIDE

SMILES

CCCCCCCC\C=C\CCCCCCCC(N)=O

InChI

InChIKey=FATBGEAMYMYZAF-MDZDMXLPSA-N
InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H2,19,20)/b10-9+

HIDE SMILES / InChI
Molecular Formula C18H35NO
Molecular Weight 281.4766
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
 63.0 nM [IC50]
Inhibitor
8297
 68.0 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Effects of oleamide on choline acetyltransferase and cognitive activities.
2003 Jun
A second fatty acid amide hydrolase with variable distribution among placental mammals.
2006 Dec 1
Gap junction communications influence upon fibroblast synthesis of Type I collagen and fibronectin.
2006 Jul 1
Patents

Patents

JP1006286A
26
JP2000063632A
2
JP2000506192A
26
JP2000513361A
2
JP2001513829A
5
JP2001520697A
3
JP2002542358A
7
JP2002543232A
9
JP2003201493A
26
JP2003323820A
27
JP2003509581A
3
JP2005330321A
4
JP2006096736A
26
JP2007536324A
4
JP2008530351A
4
JP2008545017A
3
JP2009138243A
26
JP2009501835A
26
JP2009501841A
27
JP2009504928A
3
JP2010502283A
4
JP2011046812A
2
JP2011524337A
22
JP2011529506A
3
JP2549683B2
3
JP3791928B2
26
JP4184435B2
2
JP4674254B2
4
JP4684230B2
3
JP4809845B2
27
JPH00557106A
26
JPH00673392A
26
JPH01190762A
2
JPH02169645A
3
JPH03124767A
2
JPH03203940A
26
JPH04279644A
3
JPH0463879A
26
JPH05112749A
2
JPH05140384A
2
JPH05186651A
2
JPH05246948A
26
JPH05255519A
2
JPH05279516A
2
JPH0557106A
26
JPH06116581A
26
JPH06158070A
32
JPH0673392A
26
JPH069904A
26
JPH07126449A
2
JPH07324145A
2
JPH08104885A
26
JPH08165483A
26
JPH08208683A
26
JPH08302149A
2
JPH09124921A
2
JPH09132727A
26
JPH09165472A
2
JPH0920843A
2
JPH09302148A
2
JPH11106575A
2
JPH1112402A
2
JPH111585A
2
JPH11322481A
30
JPS06320347A
2
JPS5672039A
3
JPS58118880A
2
JPS58136679A
2
JPS58176251A
2
JPS5834851A
2
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:10:13 GMT 2023
Edited
by admin
on Sat Dec 16 08:10:13 GMT 2023
Record UNII
GOU8K597IT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ELAIDAMIDE
Systematic Name English
(E)-9,10-OCTADECENAMIDE
Common Name English
ELAIDOYLAMIDE
Systematic Name English
TRANS-9-OCTADECENAMIDE
Systematic Name English
ELAIDIC ACID AMIDE
Systematic Name English
9-OCTADECENAMIDE, (9E)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID90101717
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
PRIMARY
CAS
4303-70-2
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
PRIMARY
DRUG BANK
DB03784
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
PRIMARY
CAS
3322-62-1
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
ECHA (EC/EINECS)
224-316-5
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
PRIMARY
PUBCHEM
5353370
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
PRIMARY
FDA UNII
GOU8K597IT
Created by admin on Sat Dec 16 08:10:13 GMT 2023 , Edited by admin on Sat Dec 16 08:10:13 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966